Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arzoxifene Continuation in Advanced Cancer
NCT00190697Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arzoxifene in breast cancer, endometrial cancer (EC), ovarian cancer, sponsored by Eli Lilly and Company. Started Jan 2001; status: completed.
02
Drugs
arzoxifene
03
Conditions
breast cancerendometrial cancer (EC)ovarian cancer
Beyond the preview
Go deeper on NCT00190697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190697.